Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries,”1 there was an error in Figure 1. Two panels were missing from the previous Figure that presented persistency among the 2 cohorts. A new Figure with the missing parts appears in print and this article was corrected online.
Missing Panels in Figure 1. JAMA Oncol. 2020;6(2):302. doi:10.1001/jamaoncol.2019.6910
Create a personal account or sign in to: